Preventive effect of ortho dimer of butylated hydroxyanisole on activator protein-1 activation and cyclooxygenase-2 expression in macrophages stimulated by fimbriae of Porphyromonas gingivalis, an oral anaerobe

Anticancer Research

Volumn 26, Issue 4 B, 2006, Pages 2915-2920

  Murakami, Yukio ^a   Shoji, Masao ^a   Ogiwara, Takako ^a   Tanaka, Shoji ^a   Yokoe, Ichiro ^b   Fujisawa, Seiichiro ^a  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b JOSAI UNIVERSITY   (Japan)

Author keywords

Anti inflammatory activity; AP 1; bis BHA; Butylated hydroxyanisole (BHA); Macrophage; Porphyromonas gingivalis fimbriae

Indexed keywords

3,3' DI TERT BUTYL 5,5' DIMETHOXY 1,1' BIPHENYL 2,2' DIOL; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BUTYLATED HYDROXYANISOLE; CYCLOOXYGENASE 2; FERULIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANAEROBIC BACTERIUM; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL ACTIVATION; CONTROLLED STUDY; DIMERIZATION; DRUG EFFECT; DRUG STRUCTURE; FIMBRIA; GENE EXPRESSION; INFLAMMATION; LEUKOPLAKIA; MACROPHAGE; MOUSE; NONHUMAN; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BACTEROIDACEAE INFECTIONS; BUTYLATED HYDROXYANISOLE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DIMERIZATION; ENZYME INDUCTION; MACROPHAGES; MICE; MOUTH DISEASES; PORPHYROMONAS GINGIVALIS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 33746698343     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Brekke OL, Espevic T and Bjeve KS: Butylated hydroxyanisole inhibits tumor necrosis factor-induced cytotoxicity and arachidonic acid release. Lipids 29: 91-102, 1994.
2. Shrivastava A and Aggarwal BB: Antioxidant differentially regulates activation of nuclear factor-kappa B, activator protein-1, c-jun amino-terminal kinases and apoptosis induced by tumor necrosis factor: evidence that JNK and NF-kappa B activation are not linked to apoptosis. Antioxid Redox Signal 1: 181-191, 1999.
3. Ito N, Fukushima S, Hagiwara A, Shibata M and Ogiso T: Carcinogenicity of butylated hydroxyanisole in F344 rats. J Natl Cancer Inst 70: 343-352, 1983.
4. Takahashi O, Sakamoto Y and Hiraga K: Lung hemorrhagic toxicity of butylated hydroxyanisole in the rat. Toxicol Lett 27: 15-25, 1985.
5. Della-Corte L and Sgaragli G: 2-t-Butyl-4-methoxyphenol (BHA) acute toxicity in rodents: influence of the administration route. Pharmacol Res Commun 16: 1041-1047, 1984.
6. Saito M, Sakagami H and Fujisawa S: Cytotoxicity and apoptosis induction by butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT). Anticancer Res 23: 4693-4702, 2003.
7. Thompson DC, Cha Y-N and Trush MA: The peroxidases-dependent activity of butylated hydroxianisole and butylated hydroxytoluene (BHT) to reactive intermediates. J Biol Chem 264: 3957-3965, 1989.
8. Satoh K, Sakagami H, Yokoe I, Kochi M and Fujisawa S: Interaction between eugenol-related compounds and radicals. Anticancer Res 18: 425-428, 1998.
9. Satoh K, Atsumi T, Sakagami H, Kashiwagi Y, Ida Y, Ueha T, Sugita Y, Yokoe I and Fujisawa S: Radical intensity and cytotoxicity of butylated hydroxyanisole and its orthobisphenol dimer. Anticancer Res 19: 3947-3952, 1999.
10. Kawata Y, Hanazawa S, Amano S, Murakami Y, Matsumoto T, Nishida K and Kitano S: Porphyromonas gingivalis fimbriae stimulate bone resorption in vitro. Infect Immun 62: 3012-3016, 1994.
11. Murakami Y, Iwahashi H, Yasuda H, Umemoto T, Namikawa I, Kitano S and Hanazawa S: Porphyromonas gingivalis fimbrillin is one of the fibronectin binding proteins. Infect Immun 64: 2571-2576, 1996.
12. Murakami Y, Shoji M, Hirata A, Tanaka S, Hanazawa S and Fujisawa S: Interleukin-6 negatively regulates Porphyromonas gingivalis fimbria-stimulated fibronectin expression in human gingival fibroblasts. FEMS Immunol Med Microbiol 43: 205-211, 2005.
13. Angel P and Karin K: The role of jun, fos and the AP-1 complex in cell proliferation and transcription. Biochim Biophys Acta 7072: 129-157, 1991.
14. Sawai H, Okazaki T, Yamamoto H, Okano H, Takeda Y, Tashima M, Sawada H, Okuma M, Ishihara H, Umehara H and Domae N: Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J Biol Chem 270: 27326-27331, 1995.
15. Jochum W, Passegue E and Wagner EF: AP-1 in mouse development and tumorigenesis. Oncogene 20: 2401-2412, 2001.
16. Naganuma K, Amano S, Takeda H, Kitano S and Hanazawa S: Role of transcription factor activation protein-1 in endogenous expression of the interleukin-1 β gene involved in Porphyromonas gingivalis fimbria-stimulated bone resorption in the mouse calvarial system. Oral Microbiol Immunol 15: 53-57, 2000.
17. Zhang Y and Rom WN: Regulation of the interleukin-1 beta (IL-1beta) gene by mycobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL-6 motif. Mol Cell Biol 13: 3831-3837, 1993.
18. Nakajima K and Wall R: Interleukin-6 signals activating jun B and TIS 11 gene transcription in a B-cell hybridoma. Mol Cell Biol 11: 1409-1418, 1991.
19. Xie W, Merrill JR, Bradshaw WS and Simmons DL: Structural determination and promoter analysis of the chicken mitogen-inducible prostaglandin G/H synthase gene and genetic mapping of the murine homolog. Arch Biochem Biophys 300: 247-252, 1993.
20. Yoshimura F, Takahashi K, Nodasaka Y and Suzuki T: Purification and characterization of a novel type of fimbriae from the oral anaerobe Bacteroides gingivalis. J Bacteriol 160: 949-954, 1984.
21. Bradford MM: A rapid and sensitive method for the quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
22. Hanazawa S, Takeshita A and Kitano S: Retinoic acid suppression of c-fos gene inhibits expression of tumor necrosis factor-alpha-induced monocyte chemoattractant JE/MCP-1 in clonal osteoblastic MC3T3-E1 cells. J Biol Chem 269: 21379-21384, 1994.
23. Smith PM, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ and Klenk DC: Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85, 1985.
24. 2 stimulates AP-1-mediated CD14 expression in mouse macrophages via cyclic AMP-dependent protein kinase A. J Immunol 164: 5403-5408, 2000.
25. Chomozynski P and Sacci N: Single-step method of RNA isolation by acid guanidine thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
26. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LBA and Lipsky PE: Cyclooxygenase in biology and disease. FASEB J 12: 1063-1073, 1998.
27. Chan G, Boyle JO, Yang EK, Zhang F, Sacks PG, Shah JP, Edelstein D, Soslow RA, Koki AT, Woerner BM, Masferrer JL and Dannenberg AL: Cyclooxygenase-2 expression is upregulated in squamous carcinoma of the head and neck. Cancer Res 59: 991-994, 1999.
28. Murakami Y, Shoji M, Hanazawa S, Tanaka S and Fujisawa S: Preventive effect of bis-eugenol, a eugenol ortho dimer, on lipopolysaccharide-stimulated nuclear factor kappa B activation and inflammatory cytokine expression in macrophages. Biochem Pharmacol 66: 1061-1066, 2003.
29. Murakami Y, Shoji M, Hirata A, Tanaka S, Yokoe I and Fujisawa S: Dehydrodiisoeugenol, an isoeugenol dimer, inhibits lipopolysaccharide-stimulated nuclear factor kappa B activation and cyclooxygenase-2 expression in macrophages. Arch Biochem Biophys 434: 326-332, 2005.
30. Hirata A, Murakami Y, Atsumi T, Shoji M, Ogiwara T, Shibuya K, Ito S, Yokoe I and Fujisawa S: Ferulic acid dimer inhibits lipopolysaccharide- stimulated cyclooxygenase-2 expression in macrophages. In Vivo 19: 849-854, 2005.
31. Murakami Y, Ito S, Atsumi T and Fujisawa S: Theoretical prediction of the relationship between phenol function and COX-2/AP-1 inhibition for ferulic acid-related compounds. In Vivo 19: 1039-1044, 2005.
32. Sgaragli G, Corte LD, Puliti R, De Sarlo F, Francalanci R and Gluarna A: Oxidation of 2-t-butyl-4-methoxyphenol (BHA) by horseradish and mammalian peroxidase systems. Biochem Pharmacol 29: 763-769, 1980.